References
- Alexia C, Fallot G, Lasfer M, et al., (2004). An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogene-sisand in the resistance of hepatocarcinoma cells against drug induced apoptosis. Bi-ochem Pharmacol, 68, 1003-15. https://doi.org/10.1016/j.bcp.2004.05.029
- Bota S, Piscaglia F, Bolondi L (2012). Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma. Liver cancer, 13, 190-200.
- Bertolani C, Sancho-Bru P, Failli P, et al (2006). Resistin as an Intrahepatic Cy-tokine: overexpression during chronic injury and induction of proinflammatory ac-tions in hepatic stellate cells. Am J Pathol, 169, 2042-2053. https://doi.org/10.2353/ajpath.2006.060081
- Cowey S, Hardy RW (2006). The Metabolic syndrome: a high risk state for can-cer? Am J Pathol, 169, 1505-22. https://doi.org/10.2353/ajpath.2006.051090
- Dailey G(2004) : New strategies for basal insulin treatment in type 2 diabetes melli-tus. Clin Ther, 26, 889-901. https://doi.org/10.1016/S0149-2918(04)90132-4
- Dalamaga M, Sotiropoulos G, Karmaniolas K, et al., (2013). Serum resistin: a bi-omarker of breast cancer inpostmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters. Clin Biochem, 46, 584-590. https://doi.org/10.1016/j.clinbiochem.2013.01.001
- Diehl AM(2002). Nonalcoholic steatosis and steatohepatitis. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol, 282, 1-5. https://doi.org/10.1152/ajpgi.00384.2001
- Donadon V, Balbi M, Zanette G (2009). Hyperinsulinemia and risk for hepatocel-lular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus. Expert Rev Gastroenterol Hepatol, 3, 465-7. https://doi.org/10.1586/egh.09.41
- El-Zayadi A-R, Anis M (2012). Hepatitis C virus in-duced insulin resistance impairs response to anti viral therapy. World J Gastroenterol, 18, 212-24. https://doi.org/10.3748/wjg.v18.i3.212
- Eslam M, Khattab MA, Harrison SA ( 2011). Insulin resistance and hepatitis C: An evolving story. Gut, 60, 1139-51 https://doi.org/10.1136/gut.2010.228262
- Fartoux L, Poujol-Robert A, Guechot J, et al. ( 2005). Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut, 54, 1003-8. https://doi.org/10.1136/gut.2004.050302
- Gomaa AA, Helmy AM, El Fayuomy KN, et al (2010). Role of insulin re-sistance in the development of hepatocellularcarcinoma in patients with chronic hepa-titis C. AAMJ, 8, 294-313.
- Housa D, Housova J, Vernerova Z, et al (2006). Adipocytokines and cancer. Physiol Res, 55, 233-44.
- Hsu WY, Chao YW, Tsai YL, et al (2011). Resistin induces monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothe-lial cells via p38MAPKdependent pathway. J Cell Physiol, 226, 2181-8. 45. https://doi.org/10.1002/jcp.22555
- Hui-Qi Qu, Quan Li, Anne R. Rentfro, et al (2011). The definition of insulin resistance using HOMA-IR for americans of mexican descent using machine learning. PLoS One, 6, 21041. https://doi.org/10.1371/journal.pone.0021041
- Hung CH, Wang JH, Hu TH, et al (2010). Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. World J Gastroenterol, 16, 2265-71. https://doi.org/10.3748/wjg.v16.i18.2265
- Irshad M, Iqbal A, Ansari MA, et al (2013). Relation of insulin resistance (IR) with viral etiology and blood level of cytokines in patients with liver diseases. Glo Adv Res J Med Med Sci, 2, 75-83.
- Jansson SP, Andersson DK and Svardsudd K (2010). Mortality trends in subjects with and without diabetes during 33 years of follow-up. Diabetes Care, 33, 551-556. https://doi.org/10.2337/dc09-0680
- Kakizaki S, Sohara N, Yamazaki Y, et al (2008). Elevated plasma resistin con-centrations in patients with liver cirrhosis. J Gastroenterol Hepatol, 23, 73-7. https://doi.org/10.1111/j.1440-1746.2007.05289.x
- Kawaguchi T, Taniguchi E, Itou M, et al (2011). Insulin resistance and chronic liver disease. World J Hepatol, 3, 99-107. https://doi.org/10.4254/wjh.v3.i5.99
- Kawaguchi T, Taniguchi E, Morita Y, et al (2010). Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in pa-tients with hepatitis C virus infection. Liver Int, 30, 479-86. https://doi.org/10.1111/j.1478-3231.2009.02191.x
- Martin Kopa, Jana Muchova, Zdenka Durac kova (2013). Modulation of insulin resistance by PUFA in metabolic tissues Eur. J Lipid Sci Technol, 115, 475-482. https://doi.org/10.1002/ejlt.201200229
- Mohamed AA, Loutfy SA, Craik JD, et al (2011). Chronic hepatitis C genotype-4 infection: role of insulin resistance in hepatocellular carcinoma. Virol, 8, 496. https://doi.org/10.1186/1743-422X-8-496
- Mohamed FS, El-Bardiny M, Abdel-Moety AA. et al (2014). Assessment of in-sulin resistance, serum adiponectin and ferritin levels in HCC patients before and af-ter radiofrequency ablation. JMSCR, 2, 1065-83.
- Nkontchouemail G, Bastard J, Ziol M, et al (2010). Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis. J Hepatol, 53, 827-33. https://doi.org/10.1016/j.jhep.2010.04.035
- Yagmur E, Trautwein C, Gressner AM, et al (2006). Resistin serum levels are associated with insulinresistance, disease severity, clinical complications, and prog-nosis in patients with chronic liver diseases. Am J Gastroenterol, 101, 1244-52. https://doi.org/10.1111/j.1572-0241.2006.00543.x
- Yang CC, Chang SF, Chao JK, et al (2014). Activation of AMPactivated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin. BMC Cancer, 14, 112-20. https://doi.org/10.1186/1471-2407-14-112
Cited by
- Resistin aggravates the expression of proinflammatory cytokines in cerulein-stimulated AR42J pancreatic acinar cells vol.15, pp.1, 2016, https://doi.org/10.3892/mmr.2016.6027